Opinion
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.
Opinion
Opinion
Disney tops earnings estimates as parks and streaming offer a boost
Disney reported growth at its domestic theme parks and cruises despite mounting macroeconomic uncertainty for consumers.
Opinion
Tanger CEO says World Cup drove up traffic, sales this summer
Tanger CEO Stephen Yalof said the store operator saw traffic increase in June and July due to international and domestic tourism tied to the World Cup.
Opinion
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro…
Opinion
Novo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5%
Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.
Opinion
What SpaceX’s First-Ever Earnings Reveal About Its Business
The market thrilled with SpaceX's first-ever earnings report — but big slide on Wednesday might be a buy-the-dip opportunity for investors based on what Wall Street analysts are saying about their outlook.
Opinion
SpaceX's AI spending unnerves Wall Street despite promises of quick payoff
In addressing Wall Street for the first time since SpaceX's IPO, executives tried to make the case that hefty AI investments are paying off within a year.
Opinion
Novo Nordisk shares slide after guidance disappoints investors
U.S.-traded shares of Novo Nordisk dropped about 6% on Tuesday after the Danish drugmaker released guidance that appeared to disappoint investors.
Opinion
An overlooked player in data center buildout delivers once again
Not only did results outpace expectations on both the top and bottom lines, but we also got a boost to full-year guidance.
Opinion
Lucid begins 'operational reset' as CEO says EV maker will delay midsize vehicle
Lucid Group missed Wall Street's second-quarter expectations as the electric vehicle manufacturer conducts an "operational reset" amid leadership changes and cost-cutting efforts.
Opinion
Here's why we're sticking with DuPont despite a noisy quarter
DuPont's results and guidance aren't as bad as the market's initial reaction suggested.
Opinion
The 3-Criteria Method for Identifying High-Quality Undervalued Stocks
Most investors start their stock search by chasing what’s already working. They scan for the biggest gainers, follow headlines about hot sectors, or buy whatever name keeps appearing in their social media feed.
Opinion
Saudi Aramco profits jump 33% in second quarter as Iran war squeezes oil supply
Saudi Aramco on Tuesday reported a jump in second-quarter profit, following a period of severe disruption through the Strait of Hormuz amid the sprawling Middle East conflict.
Opinion
HSBC Looks Beyond Rate Tailwinds With Wealth Expansion
Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"
Opinion
From Intel to Critical Minerals: What Washington Is Buying—and Why
Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"
Opinion
The 3 Pillars of Gold’s Secular Bull Market
Gold has corrected sharply after its best two-year run in decades, but the secular bull market remains in place.
Opinion
Jefferies cuts Ipsen on Camurus competition risk
Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"
Opinion
Jefferies downgrades Klepierre on valuation concerns
Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"
Opinion
Why did RBC downgrade JD Sports Fashion despite its 15% rally this year?
Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"
Opinion
Merlin Properties stock falls after Jefferies downgrade
Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"
Opinion
From a Fed decision to Big Tech earnings: What drove last week's volatile market
Moreover, Houthi forces in Yemen—which are aligned with Iran—now say that they will block seaborne traffic through the Strait of Bab el Mandeb, which lies at the southern end of the Red Sea and accounts for roughly 8% o…
Opinion
95% of Traders Don’t Have a Strategy Problem—They’re Bad at Discipline
The algorithmic trading market is growing fast, projected to more than double from $18.8 billion in 2025 to $43.2 billion by 2034. AI trading bots now execute the majority of volume on global equity markets. And yet, re…
Opinion
Linde's post-earnings slide is a buying opportunity. Here's why
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market moves: The S & P 500 turned relatively f…
Opinion
Eaton shares jump as its earnings and outlook show resilience of the AI buildout
A sharp rally in quantum computing stocks is drawing renewed investor attention to speculative tech, as markets shift focus to earnings season and capital spending trends.